• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interventional Transcatheter Closure Ameliorates the Leukocyte Rho Kinase Activities among Patients with Patent Ductus Arteriosus.介入性经导管封堵术改善动脉导管未闭患者的白细胞 Rho 激酶活性。
Acta Cardiol Sin. 2015 Nov;31(6):494-9. doi: 10.6515/acs20150424d.
2
Trial occlusion to assess the risk of persistent pulmonary arterial hypertension after closure of a large patent ductus arteriosus in adolescents and adults with elevated pulmonary artery pressure.试行闭塞以评估肺动脉压升高的青少年和成人大型动脉导管未闭封堵术后持续性肺动脉高压的风险。
Circ Cardiovasc Interv. 2014 Aug;7(4):473-81. doi: 10.1161/CIRCINTERVENTIONS.113.001135. Epub 2014 Aug 5.
3
[Transcatheter closure of patent ductus arteriosus using the Amplatzer duct occluder in children: initial and one-year results].[儿童使用Amplatzer动脉导管封堵器经导管闭合动脉导管未闭:初始及一年结果]
Arch Cardiol Mex. 2009 Apr-Jun;79(2):114-20.
4
Long-term outcomes of percutaneous closure of patent ductus arteriosus associated with unilateral absence of a pulmonary artery.动脉导管未闭合并单侧肺动脉缺如的经皮封堵治疗的长期疗效。
J Card Surg. 2021 Jun;36(6):2029-2034. doi: 10.1111/jocs.15495. Epub 2021 Mar 19.
5
Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.使用Amplatzer动脉导管封堵器额外尺寸-ADOIIAS对32例早产儿血流动力学显著的动脉导管未闭进行经导管封堵术。
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):612-617. doi: 10.1002/ccd.27091. Epub 2017 May 4.
6
Patent ductus arteriosus endovascular closure by amplatzer duct occluder.经导管使用Amplatzer动脉导管封堵器封堵动脉导管未闭
Georgian Med News. 2006 May(134):19-22.
7
Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.使用Occlutech动脉导管封堵器对儿童动脉导管未闭进行经导管封堵术。
Pediatr Cardiol. 2017 Dec;38(8):1598-1605. doi: 10.1007/s00246-017-1702-x. Epub 2017 Aug 21.
8
Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension in adults: immediate and two-year follow-up results.经导管封堵成人大型动脉导管未闭合并严重肺动脉高压:即刻及两年随访结果。
Chin Med J (Engl). 2012 Nov;125(21):3844-50.
9
Post-interventional Evaluation and Follow-Up in Children With Patent Ductus Arteriosus Complicated With Moderate to Severe Pulmonary Arterial Hypertension: A Retrospective Study.动脉导管未闭合并中度至重度肺动脉高压患儿介入治疗后的评估与随访:一项回顾性研究
Front Cardiovasc Med. 2021 Nov 11;8:693414. doi: 10.3389/fcvm.2021.693414. eCollection 2021.
10
Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure.经导管封堵术后动脉导管未闭合并持续性肺动脉高压
Ther Clin Risk Manag. 2016 Nov 3;12:1609-1613. doi: 10.2147/TCRM.S112400. eCollection 2016.

本文引用的文献

1
Blunted activation of Rho-kinase in yak pulmonary circulation.牦牛肺循环中Rho激酶的激活减弱。
Biomed Res Int. 2015;2015:720250. doi: 10.1155/2015/720250. Epub 2015 Jan 14.
2
Rho-kinase as a therapeutic target in vascular diseases: striking nitric oxide signaling.Rho激酶作为血管疾病的治疗靶点:显著影响一氧化氮信号传导。
Nitric Oxide. 2014 Dec 1;43:45-54. doi: 10.1016/j.niox.2014.09.002. Epub 2014 Sep 6.
3
Increased leukocyte Rho-kinase activity in a population with acute coronary syndrome.急性冠脉综合征人群白细胞 Rho 激酶活性增加。
Mol Med Rep. 2013 Jul;8(1):250-4. doi: 10.3892/mmr.2013.1463. Epub 2013 May 8.
4
Striking crosstalk of ROCK signaling with endothelial function.ROCK 信号与血管内皮功能的显著串扰。
J Cardiol. 2012 Jul;60(1):1-6. doi: 10.1016/j.jjcc.2012.03.005. Epub 2012 May 16.
5
Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.持续的治疗性高碳酸血症可减弱肺动脉 Rho 激酶活性,并改善幼年大鼠慢性低氧性肺动脉高压。
Am J Physiol Heart Circ Physiol. 2012 Jun 15;302(12):H2599-611. doi: 10.1152/ajpheart.01180.2011. Epub 2012 Apr 13.
6
Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devices.经皮动脉导管未闭封堵术:多中心注册研究比较多种封堵器。
Catheter Cardiovasc Interv. 2010 Nov 1;76(5):696-702. doi: 10.1002/ccd.22538.
7
Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.临床医生的肺动脉高压基础科学:新概念与实验性疗法
Circulation. 2010 May 11;121(18):2045-66. doi: 10.1161/CIRCULATIONAHA.108.847707.
8
Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension.吸入性法舒地尔(一种特异性Rho激酶抑制剂)对肺动脉高压患者的急性血管舒张作用。
Heart Vessels. 2010 Mar;25(2):144-9. doi: 10.1007/s00380-009-1176-8. Epub 2010 Mar 26.
9
Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension.肺动脉高压患者中Rho激酶激活的证据。
Circ J. 2009 Sep;73(9):1731-9. doi: 10.1253/circj.cj-09-0135. Epub 2009 Jul 9.
10
RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.RhoA和Rho激酶激活在人类肺动脉高压中的作用:5-羟色胺信号传导的作用
Am J Respir Crit Care Med. 2009 Jun 15;179(12):1151-8. doi: 10.1164/rccm.200805-691OC. Epub 2009 Mar 19.

介入性经导管封堵术改善动脉导管未闭患者的白细胞 Rho 激酶活性。

Interventional Transcatheter Closure Ameliorates the Leukocyte Rho Kinase Activities among Patients with Patent Ductus Arteriosus.

作者信息

Hsieh Min-Ling, Liu Ping-Yen, Wu Jing-Ming, Liao James K, Wang Jieh-Neng

机构信息

Departments of Pediatrics;

Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University; ; Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan;

出版信息

Acta Cardiol Sin. 2015 Nov;31(6):494-9. doi: 10.6515/acs20150424d.

DOI:10.6515/acs20150424d
PMID:27122913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4804973/
Abstract

BACKGROUND

Patent ductus arteriosus (PDA) causes increased pulmonary blood flow, which can lead to pulmonary arterial hypertension (PAH). Rho-associated coiled-coil containing protein kinase (ROCK) may play an important pathophysiological role in PAH. We hypothesized that the increased pulmonary artery (PA) flow from PDA could activate ROCK.

METHODS

Patients who received a PDA transcatheter closure in our hospital were consecutively enrolled in this study. Basic demographics and clinical hemodynamic data of the study participants were recorded. Then, ROCK activity was measured before and after the PDA occlusion procedure. ROCK activity was defined as the phosphorylation ratio of myosin-binding subunit by Western blot measurement. We also sub-divided patients into the coil group and occluder group based on the occlusion device used in each patient's procedure.

RESULTS

From January 2009 to December 2011, 25 patients with a median age of 2.3 years, ranging from 10 months to 72 years were enrolled. The mean PDA size was 0.31 ± 0.14 cm, the mean Qp/Qs shunt was 1.54 ± 0.41, and the mean systolic pulmonary artery pressure was 26.9 ± 10.3 mmHg. There were 10 patients (one boy and nine girls) in the coil group and 15 patients (four boys and eleven girls) in the occluder group. Following the closure of the PDA, ROCK activity significantly decreased (1.78 ± 2.25 vs. 0.77 ± 0.69, p < 0.01). There was a strong correlation between the leukocyte ROCK activity with the systolic PA pressure (y = 5.4608x + 22.54, R2 = 0.5539, p < 0.05), but not the Qp/Qs value. Both subgroups showed significant changes of ROCK activity after the procedure. Interestingly, when comparing the coil group with the occluder group, the decrease in ROCK activity was more apparent in the occluder group.

CONCLUSIONS

The findings of this study indicated that ROCK activity is higher in patients with PDA and correlates with PA pressure. The decrease in ROCK activity following the device closure suggests that ROCK may be an important biomarker for PDA patency.

KEY WORDS

Patent ductus arteriosus (PDA); Pulmonary arterial pressure; Rho kinase; Transcatheter closure.

摘要

背景

动脉导管未闭(PDA)会导致肺血流量增加,进而可能引发肺动脉高压(PAH)。含 Rho 相关卷曲螺旋的蛋白激酶(ROCK)可能在 PAH 的病理生理过程中发挥重要作用。我们推测,PDA 导致的肺动脉(PA)血流增加可能会激活 ROCK。

方法

连续纳入在我院接受 PDA 经导管封堵术的患者。记录研究参与者的基本人口统计学和临床血流动力学数据。然后,在 PDA 封堵术前和术后测量 ROCK 活性。通过蛋白质印迹法将 ROCK 活性定义为肌球蛋白结合亚基的磷酸化比率。我们还根据每位患者手术中使用的封堵装置将患者分为线圈组和封堵器组。

结果

2009 年 1 月至 2011 年 12 月,共纳入 25 例患者,中位年龄 2.3 岁,年龄范围为 10 个月至 72 岁。PDA 的平均大小为 0.31±0.14 cm,平均 Qp/Qs 分流为 1.54±0.41,平均收缩期肺动脉压为 26.9±10.3 mmHg。线圈组有 10 例患者(1 名男孩和 9 名女孩),封堵器组有 1-5 例患者(4 名男孩和 11 名女孩)。PDA 封堵术后,ROCK 活性显著降低(1.78±2.25 对 0.77±0.69,p<0.01)。白细胞 ROCK 活性与收缩期 PA 压力之间存在强相关性(y = 5.4608x + 22.54,R2 = 0.5539,p<0.05),但与 Qp/Qs 值无关。两个亚组在手术后 ROCK 活性均有显著变化。有趣的是,比较线圈组和封堵器组时,封堵器组 ROCK 活性的降低更为明显。

结论

本研究结果表明,PDA 患者的 ROCK 活性较高,且与 PA 压力相关。装置封堵后 ROCK 活性降低表明,ROCK 可能是 PDA 通畅性的重要生物标志物。

关键词

动脉导管未闭(PDA);肺动脉压;Rho 激酶;经导管封堵术